Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision identifier changed from v3.7.1 to v3.7.2. The study record still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-17T17:48:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T18:21:16.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study record content. This indicates an access issue that prevents viewing the study details.
    Difference
    17%
    Check dated 2026-09-19T22:25:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's related topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics', removing those topics from the study's contextual references.
    Difference
    0.2%
    Check dated 2026-09-12T20:23:54.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes links to related topics for Multiple Myeloma and MedlinePlus Genetics, expanding access to contextual information about the disease on the study record.
    Difference
    0.2%
    Check dated 2026-09-05T17:31:04.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A new page revision label Revision: v3.6.6 was added, indicating an update to the page metadata. The older revision label Revision: v3.6.5 and several topic tags (Multiple myeloma, related topics:, MedlinePlus Genetics) were removed, reflecting a cleanup of non-core content rather than changes to study details.
    Difference
    0.2%
    Check dated 2026-08-29T13:40:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.